Trulieve Cannabis Corp. 8-K

What Happened Trulieve Cannabis Corp. announced that Jason Pernell mutually agreed to terminate his employment as President effective June 11, 2026. The company and Mr. Pernell executed a Separation Agreement and General Release dated June 11, 2026 that outlines severance, benefit continuation, equity vesting, bonus eligibility and a one‑year restriction on monetizing company shares.

Key Details

• Termination date: June 11, 2026; 8-K filed June 12, 2026 (Item 5.02).
• Severance: a one-time payment of $15,000.
• Bonuses: contingent on compliance with the Separation Agreement, Mr. Pernell is eligible for the Q2 FY2026 quarterly performance bonus and a prorated portion of the FY2026 target performance bonus (to be paid after 2026 earnings).
• Benefits and equity: company will pay full COBRA premiums for medical/dental/vision for Mr. Pernell and covered dependents until the earlier of 18 months after termination or when he is eligible for comparable employer coverage; any issued and unvested annual equity awards vest as of the termination date.
• Transfer restriction and release: Mr. Pernell agreed not to sell, pledge, transfer or otherwise monetize the company’s subordinate voting shares or other equity securities held in his name for one year; both parties exchanged mutual releases of certain claims.

Why It Matters This filing documents a senior leadership change at Trulieve and the concrete financial and equity-related terms of the departure. For investors, the direct cash cost is limited (a $15,000 severance), but the agreement includes accelerated vesting of unvested annual awards and continued COBRA coverage (up to 18 months), which affect the company’s obligations. The one‑year restriction on monetizing shares may limit near‑term insider selling of any equity Mr. Pernell holds.